Publisher： Adis International
ISSN： 1173-8324
Source： Inpharma, Vol.1, Iss.1566, 2006-01, pp. : 3-3
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Drugs Affecting Homocysteine Metabolism: Impact on Cardiovascular Risk
By Desouza C. Keebler M. McNamara D.B. Fonseca V.
Drugs, Vol. 62, Iss. 4, 2002-04 ,pp. :
Access to resources
Recommend
Endoplasmic Stress Inhibitors for Homocysteine Induced Cardiovascular Disease
Current Pharmaceutical Design, Vol. 22, Iss. 18, 2016-05 ,pp. :
Cardiovascular Risk-Benefit Profile of Sibutramine
By Scheen A.J.
American Journal of Cardiovascular Drugs, Vol. 10, Iss. 5, 2010-10 ,pp. :